Secondary objectives were to assess influence of neutropenia on outcome of critically ill patients in prespecified subgroups (according to underlying tumor, period of admission, need for mechanical ventilation and use of granulocyte colony stimulating factor (G-CSF)). This evidence concerns the gene CSF3 and neutropenia.